Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous bone marrow-derived mesenchymal stem cell transplantation for rotator cuff lesions
2007-007630-19Phase 2Active
- Sponsor
- Hospital Clínico San Carlos
- Start
- Jan 2008
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2 trial of autologous bone marrow derived mesenchymal stromal cells in rotator cuff tear and Rotator cuff deficiency (RCD), sponsored by Hospital Clínico San Carlos. Primary endpoints: Functional and radiologic improvement of rotator cuff lesions, Progression to secondary shoulder arthropathy and 1 more. Started Jan 2008; status: active.
02
Drugs
autologous bone marrow derived mesenchymal stromal cells
03
Conditions
rotator cuff tearRotator cuff deficiency (RCD)
Beyond the preview
Go deeper on 2007-007630-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007630-19.